Co-Authors
This is a "connection" page, showing publications co-authored by Agostino Riva and Stefano Rusconi.
Connection Strength
0.681
-
Darunavir does not prevent SARS-CoV-2 infection in HIV patients. Pharmacol Res. 2020 07; 157:104826.
Score: 0.219
-
Correlation between inner retinal layer thickness and cognitive function in HIV: new insights from an exploratory study. AIDS. 2018 07 17; 32(11):1485-1490.
Score: 0.194
-
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021 06; 3(6):774-785.
Score: 0.059
-
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
Score: 0.055
-
Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy. J Med Virol. 2020 Sep; 92(9):1637-1640.
Score: 0.055
-
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis. 2018 Nov 12; 18(1):556.
Score: 0.050
-
Clinical and genetic determinants of nevirapine plasma trough concentration. SAGE Open Med. 2018; 6:2050312118780861.
Score: 0.048